| HST |
Report |
Adjusted FFO per share |
BEAT |
pred ~$0.62 vs. cons $0.60 |
MEDIUM |
| HST |
Report |
Comparable hotel RevPAR growth |
BEAT |
pred ~5.1% vs. cons 4.6% |
MEDIUM |
| HST |
Report |
Adjusted EBITDAre |
BEAT |
pred ~$532M vs. cons $524M |
MEDIUM |
| HST |
Guide |
FY2026 comparable hotel RevPAR growth |
UNCHANGED |
guide ~3.75% midpoint vs. cons 3.8% (FY2026) |
MEDIUM |
| HST |
Guide |
FY2026 Adjusted EBITDAre |
UNCHANGED |
guide ~$1.810B midpoint vs. cons $1.812B (FY2026) |
MEDIUM |
| HST |
Guide |
FY2026 Adjusted FFO per share |
UNCHANGED |
guide ~$2.13 midpoint vs. cons $2.13 (FY2026) |
MEDIUM |
| HST |
Return |
Day-1 residual (stock − beta × S&P 500) |
+2.4% |
— |
MEDIUM |
| HST |
Return |
5-day cumulative residual |
+0.8% (FADE) |
A ~$0.02 quarterly FFO beat versus ~$0.60 consensus and ~$8M EBITDAre beat versus ~$524M consensus should support an initial positive reaction, but unchanged ~$2.13 FY2026 FFO guidance versus ~$2.13 consensus leaves limited out-period estimate upside after the World Cup-weighted quarter. |
MEDIUM |